Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gilead (GILD), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) are some of the most trending stocks in the biotech sector. See how they compare to other companies such as Biogen (BIIB), Illumina (ILMN) and Regeneron (REGN).
Comparison Results
Name | Price | Price Change | Analyst Price Target | Analyst Consensus | Volume | Market Cap | Smart Score | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences | $75.01 | $0.26 (-0.35%) | $89.63 (19.49% Upside) | 9 Buy 6 Hold 1 Sell Moderate Buy | 4.35M | $93.46B | premium | ||
Amgen | $267.70 | $1.71 (-0.63%) | $255.31 (-4.63% Downside) | 7 Buy 5 Hold 2 Sell Moderate Buy | 1.89M | $143.19B | premium | ||
Vertex Pharmaceuticals | $349.53 | $4.75 (-1.34%) | $382.74 (9.50% Upside) | 16 Buy 5 Hold 0 Sell Strong Buy | 938.79K | $90.21B | premium | ||
Biogen | $257.68 | $1.25 (-0.48%) | $327.17 (26.97% Upside) | 20 Buy 7 Hold 0 Sell Moderate Buy | 800.83K | $37.32B | premium | ||
Illumina | $132.44 | $0.89 (-0.67%) | $219.29 (65.58% Upside) | 7 Buy 6 Hold 2 Sell Moderate Buy | 1.93M | $20.97B | premium | ||
Regeneron | $824.84 | $1.46 (0.18%) | $897.35 (8.79% Upside) | 13 Buy 4 Hold 1 Sell Moderate Buy | 464.60K | $88.04B | premium | ||
Moderna | $99.99 | $0.24 (-0.24%) | $166.25 (66.27% Upside) | 7 Buy 6 Hold 1 Sell Moderate Buy | 2.28M | $38.06B | premium | ||
BioNTech SE | $104.64 | $1.79 (-1.68%) | $136.67 (30.61% Upside) | 4 Buy 5 Hold 0 Sell Moderate Buy | 470.67K | $25.43B | premium | ||
IQVIA Holdings | $198.75 | $0.43 (-0.22%) | $251.83 (26.71% Upside) | 11 Buy 2 Hold 0 Sell Strong Buy | 1.09M | $36.40B | premium |
Performance Comparison
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.
Biotech Stocks Latest News
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Biotech Stocks
Biogen
premium
premium
Buy
premium
premium
Reiterated
Amgen
premium
premium
Buy
premium
premium
Reiterated
Regeneron
premium
premium
Buy
premium
premium
Reiterated
Moderna
premium
premium
Hold
premium
premium
Reiterated
Gilead Sciences
premium
premium
Buy
premium
premium
Assigned
BioNTech SE
premium
premium
Hold
premium
premium
Reiterated
Vertex Pharmaceuticals
premium
premium
Buy
premium
premium
Assigned
IQVIA Holdings
premium
premium
Buy
premium
premium
Initiated
Illumina
premium
premium
Sell
premium
premium
Reiterated
Moderna
premium
premium
Buy
premium
premium
Reiterated
Most Recent Earnings of Biotech Stocks
Gilead Sciences
Aug 03, 2023
Jun 01, 2023
1.58
Amgen
Aug 03, 2023
Jun 01, 2023
4.65
Vertex Pharmaceuticals
Aug 01, 2023
Jun 01, 2023
3.6
Biogen
Jul 25, 2023
Jun 01, 2023
5.25
Illumina
Aug 09, 2023
Jun 01, 2023
0.57
Regeneron
Aug 03, 2023
Jun 01, 2023
9.77
Moderna
Aug 03, 2023
Jun 01, 2023
5.24
BioNTech SE
Aug 07, 2023
Jun 01, 2023
6.883
IQVIA Holdings
Aug 01, 2023
Jun 01, 2023
2.44
Biotech Stocks - FAQ
Which Biotech stocks have a "Strong Buy" analyst rating?
These Biotech stocks currently have a "Strong Buy" analyst rating consensus:
Vertex Pharmaceuticals - Strong Buy, based on 21 analyst ratings, 16 Buy, 5 Hold, and 0 Sell.
IQVIA Holdings - Strong Buy, based on 13 analyst ratings, 11 Buy, 2 Hold, and 0 Sell.
Are Biotech stocks overpriced?
Gilead Sciences's stock price is currently $75.01, and its average 12-month price target is $89.63.
Amgen's stock price is currently $267.70, and its average 12-month price target is $255.31.
Vertex Pharmaceuticals's stock price is currently $349.53, and its average 12-month price target is $382.74.
Biogen's stock price is currently $257.68, and its average 12-month price target is $327.17.
Illumina's stock price is currently $132.44, and its average 12-month price target is $219.29.
Regeneron's stock price is currently $824.84, and its average 12-month price target is $897.35.
Moderna's stock price is currently $99.99, and its average 12-month price target is $166.25.
BioNTech SE's stock price is currently $104.64, and its average 12-month price target is $136.67.
IQVIA Holdings's stock price is currently $198.75, and its average 12-month price target is $251.83.
Which Biotech stocks pay dividends?
Gilead Sciences does not currently pay dividends.
Amgen does not currently pay dividends.
Vertex Pharmaceuticals does not currently pay dividends.
Biogen does not currently pay dividends.
Illumina does not currently pay dividends.
Regeneron does not currently pay dividends.
Moderna does not currently pay dividends.
BioNTech SE does not currently pay dividends.
IQVIA Holdings does not currently pay dividends.
Popular Stocks Comparisons
5g StocksAirline StocksArtificial Intelligence StocksBank StocksBeer & Beverages StocksBiotech StocksBitcoin StocksBlockchain StocksBlue Chip StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksChips StocksCloud & Storage StocksCryptocurrency StocksCybersecurity StocksDividend StocksElectric Vehicle StocksEnergy StocksFAANG StocksGold StocksGreen Energy StocksGreen Hydrogen StocksGrowth StocksHealthcare StocksHotel StocksLarge Cap StocksMATANA StocksMega Cap StocksMetaverse StocksOil StocksRussia-Ukraine War Affected StocksSocial Media StocksSolar StocksTech StocksUtility StocksValue StocksVirtual Reality StocksWallStreetBets Stocks
Latest News
Biotech Stock Events
Stock | Type | Date |
|---|---|---|
Biogen | Earnings Release | Oct 24, 2023 |
IQVIA Holdings | Earnings Release | Oct 24, 2023 |
Gilead Sciences | Earnings Release | Oct 26, 2023 |
Amgen | Earnings Release | Oct 31, 2023 |
Vertex Pharmaceuticals | Earnings Release | Nov 01, 2023 |